Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3979011 | Bulletin du Cancer | 2012 | 5 Pages |
Abstract
Most of patients with endometrial cancer are diagnosed at an early stage and therapeutics should be more limited in order to decrease morbidity. New French recommendations have been published in 2010, integrating this objective of therapeutic de-escalation. This review presents the take home messages of these recommendations (pretherapeutic staging, new FIGO staging and its criticism, evolution of surgical treatment more limited for low risk patients, management of specific histology, postoperative treatment, follow up) and the possible difficulties in the daily use of these recommendations. Indeed, the current recommended management for endometrial cancer is more complex but the ultimate goal is to tailor treatment at best for each patient.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Catherine Uzan, Sébastien Gouy, Patricia Pautier, Catherine Lhommé, Pierre Duvillard, Christine Haie-Meder, Philippe Morice,